Claim: Do bird flu vaccines approved by the FDA kill 1 in 200 recipients, as viral social media posts claim?

First requested: June 25, 2026 at 8:51 AM
19%

IsItCap Score

Truth Potential Meter

Not Credible

AI consensusWeak

Grader consensus is weak.
Range 0%–95% (spread Δ95).
The graders diverge. Treat the combined score as uncertain and read the sources carefully.
Read analysis summary

OpenAI Grade

0%
20%
40%
60%
80%
10%

Perplexity Grade

0%
20%
40%
60%
80%
0%

Google Gemini Grade

0%
20%
40%
60%
80%
95%
Shareable summary
Verdict: Questionable
  • FDA explicitly states no vaccine-related deaths occurred in the trial.
  • Public Health Collaborative debunks the claim, noting trial deaths were unrelated to the vaccine.
/r/fact-check-bird-flu-vaccines-kill-1-in-200

Analysis Summary

The claim that FDA-approved bird flu vaccines kill 1 in 200 recipients is false. Official sources, including the FDA and public health organizations, confirm that no vaccine-related deaths were reported during trials. The claim appears to stem from misinformation circulating on social media. There are no credible studies or evidence supporting this assertion, which undermines its validity. The models diverge sharply — treat this as higher-uncertainty. Gemini comes in highest (95%), while Perplexity is lowest (0%). While the claim is strongly disputed by credible sources, there may be concerns about vaccine safety in general, which some individuals cite. However, these concerns do not specifically support the claim of a 1 in 200 mortality rate. The absence of any reported vaccine-related deaths in FDA assessments further solidifies the conclusion that the claim lacks factual basis. Thus, the existence of opposing views does not alter the overall verdict of falsehood regarding this specific claim.

Source quality

Truth (from sources)1.00 / 10
Source reliability9.00 / 10
Source independence8.00 / 10

Claim checks

Fits established facts10.00 / 10
Logical consistency10.00 / 10
Expert consensus10.00 / 10

Source Analysis

Common arguments
Supporting the claim
  • Social media posts claim the 2020 FDA vaccine killed 1 in 200 recipients, citing trial deaths.
  • Some users argue trial deaths were not properly investigated for vaccine links.
  • Viral posts suggest FDA data is incomplete or misleading about vaccine safety.
Against the claim
  • FDA explicitly states no vaccine-related deaths occurred in the trial.
  • Public Health Collaborative debunks the claim, noting trial deaths were unrelated to the vaccine.
  • No commercially available bird flu vaccines exist for the general public; stockpiled vaccines are for high-risk groups only.

Mainstream Sources

Publication

Public Health Collaborative

Title

False claims about bird flu and vaccines continue to circulate

Summary

The claim that a 2020 FDA-approved bird flu vaccine killed one in 200 recipients is debunked, as deaths in the trial were not related to the vaccine.

Source details

Publication

FDA

Title

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted - FDA

Summary

FDA determined the vaccine's benefits outweigh risks, with the most common side effect being injection site pain and no vaccine-related deaths reported.

Source details

Publication

Yale Medicine

Title

H5N1 Bird Flu: What You Need to Know

Summary

There are currently no commercially available bird flu vaccines for the general public, though FDA-approved antiviral drugs exist for treatment.

Source details

Alternative Sources

No alternative sources were found for this analysis.

Analysis Breakdown

True/False Spectrum (1.0)Source Credibility (9.0)Bias Assessment (8.0)Contextual Integrity (10.0)Content Coherence (10.0)Expert Consensus (10.0)80%

How to read the breakdown

Weakest areas
Truth1.0/10Independence8.0/10
  • Truth: how well sources support the core claim.
  • Source reliability: whether the sources have a strong track record.
  • Independence: whether coverage looks one-sided or recycled.
  • Context: missing details (timeframe, definitions, scope) that change meaning.
  • Tip: if graders disagree, rely more on the summary + sources than the single number.

Detailed AnalysisPremium Feature

Get an in-depth analysis of content accuracy, source credibility, potential biases, contextual factors, claim origins, and hidden perspectives.

Create a free account to unlock premium features.

Methodology